Sarcoidosis and risk of venous thromboembolism: A systematic review and meta-analysis

© Mattioli 1885. Background: Several chronic inflammatory disorders, such as rheumatoid arthritis, inflammatory myositis and systemic lupus erythematosus, have been linked to an increased risk of venous thromboembolism (VTE). However, the data on sarcoidosis is unclear. Objectives: To evaluate the r...

全面介紹

Saved in:
書目詳細資料
Main Authors: Patompong Ungprasert, Narat Srivali, Karn Wijarnpreecha, Charat Thongprayoon
格式: 雜誌
出版: 2018
主題:
在線閱讀:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84941617689&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/54781
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
實物特徵
總結:© Mattioli 1885. Background: Several chronic inflammatory disorders, such as rheumatoid arthritis, inflammatory myositis and systemic lupus erythematosus, have been linked to an increased risk of venous thromboembolism (VTE). However, the data on sarcoidosis is unclear. Objectives: To evaluate the risk of VTE among patients with sarcoidosis. Methods: We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio or standardized incidence ratio comparing risk of VTE in patients with sarcoidosis versus non-sarcoidosis participants. Estimated effects were extracted from each study and were pooled together using the random-effect, generic inverse variance method of DerSimonian and Laird. Result: Out of 772 potentially relevant articles, three eligible studies were identified and included in the data analysis. The pooled risk ratio of VTE in patients with sarcoidosis was 1.42 (95% CI, 1.12-1.79). The statistical heterogeneity of this study was moderate with an I2 of 72%. Conclusion: Our study demonstrated a statistically significant increased VTE risk among patients with sarcoidosis.